Tempus AI stock falls around 5.5% as shares slip despite strong revenue growth and new partnerships

Traders Union
All News
Stocks
Tempus ai slides 5.53% today

Highlights

Tempus AI reported Data and Applications revenue rose 33% in the third quarter and signed up to $192.5 million in new five-year commercial contracts with Bristol Myers Squibb and Pathos for oncology and Alzheimer’s data and models.
The company entered multi-year collaborations with Moderna and Merck to support potential commercialization of melanoma and other cancer treatments, and ARK Invest acquired 154,521 shares for its Innovation and Genomic Revolution ETFs.
Shares of Tempus AI remain in a broadly bullish technical structure but saw a session drop of 5.53% with high volatility; the next five-day price range is projected at $69.52 to $90.02, with technical signals cautioning overheating risk near resistance at $83.44.

Revenue surge and major deals draw inflows amid persistent selling

Tempus AI, Inc. reported a 33% increase in third-quarter Data and Applications revenue and announced new five-year commercial contracts with Bristol Myers Squibb and Pathos, valued at up to $192.5 million combined for oncology and Alzheimer’s data and models. The company also revealed multi-year collaborations with Moderna and Merck to support potential commercialization of treatments for melanoma and other cancers. Additionally, ARK Invest acquired 154,521 shares for its Innovation and Genomic Revolution ETFs, though price action has remained under broader selling pressure.

Anton Kharitonov, expert at Traders Union, sees Tempus AI's price action as disconnected from its underlying bullish technicals and major partnership news. He notes that despite the supportive fundamentals — including substantial contracts and institutional buying — sellers dominate and key technical momentum remains weak. The presence of overbought oscillators and a relatively low ADX suggest increased risk of correction. Kharitonov asserts that the break below near-term support at $79.1 would confirm a bearish scenario. "Caution is warranted here, as recent commercial wins are not yet reflected in sustained price strength and downside volatility remains a significant threat."

Viktoras Karapetjanc, expert at Traders Union, highlights Tempus AI's robust growth, with strong data revenue and strategic partnerships fueling a bullish outlook. He points to ongoing institutional interest and new five-year contracts with industry leaders as strong validation of future value. Karapetjanc believes the underlying bullish technical structure remains intact, even after a temporary pullback. He sees the current setup as an opportunity for further growth if resistance breaks. "Strength in fundamentals and investor appetite point to a resilient market, and I expect upward momentum to resume near $83.44."

Parshwa Turakhiya, analyst, observes increased volatility and a notable gap down despite positive headlines. He sees short-term sentiment as divided, with a bullish long-term structure conflicting with overbought technical signals. Turakhiya cautions that sideways or corrective moves may emerge before any renewed trend. "Aggressive traders should watch $83.44 for upside confirmation, but risk management is key as tempers could cool following recent excess."

Bullish technical alignment faces loss of momentum and overbought risk

Tempus AI is trading above its MA-20 at $71.59, MA-50 at $71.73, and MA-200 at $57.23, reflecting a bullish structure across all timeframes. Resistance is found at $83.44, with near-term support at $79.1. The upward alignment of the MA-50 and MA-200 further confirms long-term bullish momentum. MACD and the Awesome Oscillator remain positive, but momentum strength is moderate based on an ADX reading of 16.69. The RSI is neutral, showing no overbought or oversold pressure. However, the Stochastic RSI and Commodity Channel Index (CCI) are both in overbought territory, indicating increased risk of a near-term correction or cooling off. Bull/Bear Power (BBP) is firmly positive at 10.72, indicating buyer dominance during intraday trading. Early in the session, the stock gapped down by $2.07, then dropped to $79.77 amid increased volatility of 5.49%. Sellers controlled the session and pushed the price toward its low of the day, although a broader reversal is not yet confirmed.

Earlier, analysts highlighted Tempus AI's persistent bullish momentum following robust earnings and expanded pharmaceutical partnerships. The current pullback adds a new dimension to the outlook, as technical signals suggest monitoring support at $79.1 for signs of sustained downside risk or potential stabilization within the projected volatility band.

Source of Data: TEM Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.